Welcome : Guest

Biocon Ltd. (India) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Biocon Ltd., which is principally involved in Biopharmaceuticals Business. Illustrated with 82 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-05587
Price: $3500
Company Type: Public
Pages: 86
Date: June 2016
Market Data Tables: 82

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Biocon Ltd.’s (Operation) Sales by Geographic Region Worldwide (2015-2016) in Percentage for India, and Others......4
Table 2: Biocon Ltd.’s (Operation) Sales by Business Segment Worldwide (2015-2016) in Percentage for Pharma, and Contract Research......5
Table 3: Biocon Ltd.’s (Operation) Sales by Product Category Worldwide (2016) in Percentage for Finished Goods, Traded Goods, Licensing and Development Fees, Contract Research and Manufacturing Services Income, and Others......6
Active Pharmaceutical Ingredients (API)......7
Table 4: Generic Active Pharmaceutical Ingredients Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Avapro Avalide, Benicar HCT, Cozaar Hyzaar, Diovan HCT, and Others......7
Table 5: Active Pharmaceutical Ingredient Market for Small Molecules by Category Worldwide (2014) - Percentage Share Breakdown by Value for Generics (Outsourced), In-House, and Patent-Protected (Outsourced)......8
Table 6: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for In-House Manufacturing, and Outsourced to CMOs......9
Table 7: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment in China (2014) - Percentage Share Breakdown by Value Sales for Biomanufacturing, HPAPI Manufacturing, and Small Molecules API Manufacturing......10
Allergy Immunotherapy......11
Table 8: Allergy Immunotherapy Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, France, Germany, Italy, Spain and Others......11
Cardiology Market......12
Table 9: Cardiovascular Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......12
Table 10: Cardiology Market by Category in the US (2014) - Percentage Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Anti-Arrhythmics, ARB's, Beta Blockers, Calcium Blockers, Cholesterol, Digitalis, Diuretics, Vasodilators, and Others......13
Diabetes Market......14
Table 11: Type II Diabetes Market by Insulin Treatment Worldwide (2015) - Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......14
Table 12: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type‐1 Diabetes, Insulin Type‐2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP‐1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others* (includes Sodium-Glucose Co-Transporter-2 (SGLT2), Biguanide, Sulfonylurea, Alpha-Glucosidase Inhibitors, Peroxisome Proliferator-Activated Receptor (PPAR)......15
Table 13: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......16
Table 14: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......17
Table 15: No. of Diabetes Patients by Medication in the US (2014) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......18
Diabetes Drugs......19
Table 16: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......19
Table 17: Diabetes/Metabolic Drugs Market by Category Worldwide (2014) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......20
Table 18: Anti-Diabetic Drug Market by Treatment Class Worldwide (2014) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......21
Table 19: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......22
Table 20: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......23
Table 21: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......24
Table 22: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......25
Insulin......26
Table 23: Insulin Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Aspart (Novolog), Detemir (Levemir), Glargine (Lantus), Glulisine (Apidra), Lispro (Humalog), and Rh Insulin......26
Table 24: Insulin Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Basal Insulins, Prandial Insulins and Pre-Mixed Insulin......27
Oncology Market......28
Table 25: Oncology Genomics (Clinical, Hereditary, and Molecular Monitoring) Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......28
Table 26: Hereditary Oncology Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......29
Table 27: Oncology Genomics Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......30
Table 28: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......31
Table 29: Oncology Market by Product Segment Worldwide (2014) - Percentage Breakdown by Value for Dialysis Catheters, Enteral Feeding, Peripherally Inserted Central Catheters, Ports, Ultrasound, and Others......32
Table 30: Clinical Oncology Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......33
Table 31: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......34
Table 32: Oncology Genomics Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......35
Table 33: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......36
Oncology Drugs......37
Table 34: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......37
Table 35: Oncology/Hematology Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......38
Chronic Diseases......39
Table 36: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2014) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......39
Table 37: No. of Chronic Obstructive Pulmonary Disease (COPD) Patients Worldwide (2014) - Percentage Market Share Breakdown for Europe, North America, and Rest of World......40
Table 38: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......41
Table 39: Chronic Obstructive Pulmonary Disease (COPD) and Asthma Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Flixotide and Flovent, Seretide and Advair, Spiriva, Symbicort, Xolair, and Others......42
Table 40: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2014) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......43
Table 41: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2014) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......44
Table 42: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2014) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......45
Table 43: Chronic Kidney Disease Market by Drug in the US (2014) - Percentage Share Breakdown by Value Sales for Aranesp and Others......46
Injectables......47
Table 44: Standard Injectables Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Anti-Infectives, Blood, Oncology and Others......47
Table 45: Injectables Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Biologics, Standard Injectables, Vaccines and Others......48
Table 46: Injectable Products Market by Type in Europe (2014) - Percentage Breakdown by Value Sales for Biologics, Biosimilars, Branded Injectables and Generic Injectables......49
Cancer Market......50
Table 47: Cancer Care Expenditure by Site Worldwide (2014) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others*......50
Table 48: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......51
Table 49: Hematological Cancer by Category Worldwide (2014) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......52
Table 50: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......53
Table 51: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......54
Table 52: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......55
Table 53: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......56
Table 54: No. of Solid Cancer Tumor Patients by Type Worldwide (2014) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......57
Table 55: Number of Cancer Patients by Type in the US (2014) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......58
Table 56: Number of Cancer Patients by Type Worldwide (2014) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......59
Anti-Cancer Drugs......60
Table 57: Anti-Cancer Drugs Market by Product Type in China (2014) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......60
Table 58: Anti-Cancer Drugs Market by Type in China (2014) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......61
Biosimilar Drugs......62
Table 59: Market Shares of Leading Biosimilar Drug Producing Companies in Europe (2015) - Percentage Share Breakdown by Value for Hospira, Inc., Sandoz, Teva Pharmaceuticals Industries Ltd. and Others......62
Oncology Drugs......63
Table 60: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......63
Table 61: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......64
Table 62: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......65
Breast Cancer Drugs......66
Table 63: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......66
Allergy Immunotherapy......67
Table 64: Market Shares of Leading Bulk Extract Allergy Immunotherapy Manufacturers in the US (2015) - Percentage Breakdown by Value for ALK, Greer Laboratories, Inc., HollisterStier LLC and Others......67
Table 65: Market Shares of Leading Allergy Immunotherapy Treatment Providers in the UK (2015) - Percentage Breakdown by Value for ALK, Allergopharma, Allergy Therapeutics, HAL Allergy, Leti/Novartis, Stallergenes, and Others......68
Cardiology Therapeutics......69
Table 66: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......69
Diabetes Drugs......70
Table 67: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......70
Table 68: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......71
Table 69: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......72
Insulin......73
Table 70: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A., and Others......73
Table 71: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Volume Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A., and Others......74
Table 72: Market Shares of Leading Insulin Companies in China (2014) - Percentage Share Breakdown by Value for Eli Lilly and Company, GanLee Pharmaceutical Co., Ltd., Novo Nordisk, Sanofi S.A., Shanghai Fosun Pharmaceutical Group Co., Ltd., United Laboratories International Holdings Ltd. (The), Tonghua Dongbao Pharmaceutical Co., Ltd., and Others......75
Table 73: Market Shares of Leading Insulin Companies in China (2015) - Percentage Share Breakdown by Volume for Novo Nordisk, Tonghua Dongbao Pharmaceutical Co., Ltd., Wanbang Biopharmaceuticals Co., Ltd. and Others......76
Table 74: Market Shares of Leading Human Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Eli Lilly and Company India Pvt. Ltd., Novo Nordisk India Limited, Sanofi India Limited, Wockhardt Ltd., and Others......77
Table 75: Market Shares of Leading Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Ltd., Cadila Pharmaceuticals Ltd., Eli Lilly and Company India Pvt. Ltd., Lupin Pharmaceuticals, Inc., Novo Nordisk India Ltd., Pfizer India Ltd., Ranbaxy Laboratories Ltd., Sanofi India Ltd., Shreya Life Sciences Pvt. Ltd., USV Ltd., and Wockhardt Ltd.......78
Table 76: Market Shares of Leading Insulin Companies in Europe (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......79
Table 77: Market Shares of Leading Insulin Companies in Japan and Korea (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......80
Table 78: Market Shares of Leading Insulin Companies in North America (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......81
Glargine......82
Table 79: Market Shares of Leading Glargine Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Pfizer India Limited, Sanofi India Limited and Wockhardt Ltd.......82
Table 80: Biocon Ltd.’s Sales by Geographic Region Worldwide (2013-2014) in Percentage for India and Outside India......83
Table 81: Biocon Ltd.’s Revenues by Category Worldwide (2013-2014) in Rs Millions for Finished Goods, Traded Goods, Licensing and Development Fees, Contract Research and Manufacturing Services Income, Sale of Process Waste and Others......84
Table 82: Biocon Ltd.’s Sales by Business Segment Worldwide (2013-2014) in Percentage for Pharma and Contract Research......85